Join
Live feed
·
SECFilingvia Quantisnow
20/20 Biolabs Inc. logo

20/20 Biolabs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
AIDX· 20/20 Biolabs Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AIDX (20/20 Biolabs Inc.) and more on Quantisnow.